Stifel raises Revolution Medicines price target to $230 from $215
Stifel maintained Revolution Medicines at Buy and raised its price target to $230.00 per share from $215.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.